clinical analysis
The Importance of Simulation and Modelling in Clinical Trial Design
February 18 by Pharmaceuticals & Biotechnology EditorAdaptive and Group Sequential Clinical Methods for Clinical Trial Design
November 11 by Pharma IQChris Jennison, Professor of Statistics at the University of Bath, talks to Helen Winsor from Pharma IQ, about adaptive and group sequential clinical methods for clinical trial design and how i...
Where is Health Technology Assessment Going?
November 04 by Pharma IQChrissie Fletcher, Director and Head of International Biostatistics at Amgen, talks to Helen Winsor from Pharma IQ, about innovation in clinical design, analysis and reporting. Fletcher disc...
Challenges and Opportunities in the Use of Biomarkers in Early Phase Trials
October 07 by Pharma IQIn this interview Martin Jenkins, Senior Statistician at AstraZeneca, speaks to Andrea Charles from Pharma IQ, about exploring the potential uses of biomarkers to enhance early clinical development,...
Bringing Innovation to Clinical Design
September 28 by Pharma IQClinical trials may be one of the most fundamental parts of drug development work carried out in the pharmaceutical industry, but they still remain a complicated area for pharma companies to address....
Adaptive Design, Often Maligned
September 22 by Pharma IQWhen carried out well, adaptive trials not only provide evidence of safety and efficacy more quickly, but also allow you to assess that evidence and get answers earlier. In this inter...